These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 3036259

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. OCD: where the serotonin selectivity story begins.
    Pigott TA.
    J Clin Psychiatry; 1996; 57 Suppl 6():11-20. PubMed ID: 8647793
    [Abstract] [Full Text] [Related]

  • 23. Serotonergic responsivity in obsessive-compulsive disorder. Comparison of patients and healthy controls.
    Zohar J, Mueller EA, Insel TR, Zohar-Kadouch RC, Murphy DL.
    Arch Gen Psychiatry; 1987 Nov; 44(11):946-51. PubMed ID: 3675134
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Single photon emission computed tomography of the brain with Tc-99m HMPAO during sumatriptan challenge in obsessive-compulsive disorder: investigating the functional role of the serotonin auto-receptor.
    Stein DJ, Van Heerden B, Wessels CJ, Van Kradenburg J, Warwick J, Wasserman HJ.
    Prog Neuropsychopharmacol Biol Psychiatry; 1999 Aug; 23(6):1079-99. PubMed ID: 10621951
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Essential role for orbitofrontal serotonin 1B receptors in obsessive-compulsive disorder-like behavior and serotonin reuptake inhibitor response in mice.
    Shanahan NA, Velez LP, Masten VL, Dulawa SC.
    Biol Psychiatry; 2011 Dec 01; 70(11):1039-48. PubMed ID: 21920503
    [Abstract] [Full Text] [Related]

  • 29. Clomipramine, clonazepam, and clonidine treatment of obsessive-compulsive disorder.
    Hewlett WA, Vinogradov S, Agras WS.
    J Clin Psychopharmacol; 1992 Dec 01; 12(6):420-30. PubMed ID: 1474179
    [Abstract] [Full Text] [Related]

  • 30. Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results.
    Pigott TA, Pato MT, Bernstein SE, Grover GN, Hill JL, Tolliver TJ, Murphy DL.
    Arch Gen Psychiatry; 1990 Oct 01; 47(10):926-32. PubMed ID: 2222131
    [Abstract] [Full Text] [Related]

  • 31. Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders.
    Hoehn-Saric R, Ninan P, Black DW, Stahl S, Greist JH, Lydiard B, McElroy S, Zajecka J, Chapman D, Clary C, Harrison W.
    Arch Gen Psychiatry; 2000 Jan 01; 57(1):76-82. PubMed ID: 10632236
    [Abstract] [Full Text] [Related]

  • 32. Pharmacotherapy of obsessive compulsive disorder.
    Goodman WK, McDougle CJ, Price LH.
    J Clin Psychiatry; 1992 Apr 01; 53 Suppl():29-37. PubMed ID: 1532962
    [Abstract] [Full Text] [Related]

  • 33. Paraphilias: a double-blind crossover comparison of clomipramine versus desipramine.
    Kruesi MJ, Fine S, Valladares L, Phillips RA, Rapoport JL.
    Arch Sex Behav; 1992 Dec 01; 21(6):587-93. PubMed ID: 1482282
    [Abstract] [Full Text] [Related]

  • 34. Clomipramine: an antiobsessional tricyclic antidepressant.
    Peters MD, Davis SK, Austin LS.
    Clin Pharm; 1990 Mar 01; 9(3):165-78. PubMed ID: 2180623
    [Abstract] [Full Text] [Related]

  • 35. Predictive value of obsessive-compulsive personality disorder in antiobsessional pharmacological treatment.
    Cavedini P, Erzegovesi S, Ronchi P, Bellodi L.
    Eur Neuropsychopharmacol; 1997 Feb 01; 7(1):45-9. PubMed ID: 9088884
    [Abstract] [Full Text] [Related]

  • 36. Role of serotonin in obsessive-compulsive disorder.
    Baumgarten HG, Grozdanovic Z.
    Br J Psychiatry Suppl; 1998 Feb 01; (35):13-20. PubMed ID: 9829022
    [Abstract] [Full Text] [Related]

  • 37. Serotonergic function in obsessive-compulsive disorder. Behavioral and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers.
    Hollander E, DeCaria CM, Nitescu A, Gully R, Suckow RF, Cooper TB, Gorman JM, Klein DF, Liebowitz MR.
    Arch Gen Psychiatry; 1992 Jan 01; 49(1):21-8. PubMed ID: 1728249
    [Abstract] [Full Text] [Related]

  • 38. Pharmacotherapy of childhood obsessive-compulsive disorder.
    Leonard HL, Rapoport JL.
    Psychiatr Clin North Am; 1989 Dec 01; 12(4):963-70. PubMed ID: 2690035
    [Abstract] [Full Text] [Related]

  • 39. A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory.
    Jenike MA, Hyman S, Baer L, Holland A, Minichiello WE, Buttolph L, Summergrad P, Seymour R, Ricciardi J.
    Am J Psychiatry; 1990 Sep 01; 147(9):1209-15. PubMed ID: 2143637
    [Abstract] [Full Text] [Related]

  • 40. A double-blind, placebo controlled study of trazodone in patients with obsessive-compulsive disorder.
    Pigott TA, L'Heureux F, Rubenstein CS, Bernstein SE, Hill JL, Murphy DL.
    J Clin Psychopharmacol; 1992 Jun 01; 12(3):156-62. PubMed ID: 1629380
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.